Treatment-resistant systemic lupus erythematosus-associated hypocomplementic urticarial vasculitis successfully treated with belimumab

Australas J Dermatol. 2023 May;64(2):301-303. doi: 10.1111/ajd.13995. Epub 2023 Feb 6.
No abstract available

Keywords: belimumab; hypocomplementemic urticarial vasculitis; systemic lupus erythematosus; urticarial vasculitis; vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / drug therapy
  • Urticaria* / drug therapy
  • Urticaria* / etiology
  • Vasculitis* / drug therapy

Substances

  • belimumab
  • Antibodies, Monoclonal, Humanized